|
Volume 271,
Number 12,
Issue of March 22, 1996 pp. 6708-6712
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.
Growth Hormone
(GH) and a GH Antagonist Promote GH Receptor Dimerization and
Internalization
(Received for publication, September 5, 1995; and in revised form, December
20, 1995)
Paul A.
Harding ,
Xinzhong
Wang,
Shigeru
Okada,
Wen
Y.
Chen,
Wen
Wan,
John J.
Kopchick
It has previously been shown that a human growth hormone (hGH)
analog, hGH-G120R, acts as a GH antagonist (Chen, W. Y., Wight, D. C.,
Wagner, T. E., and Kopchick, J. J.(1990) Proc. Natl. Acad. Sci. U.
S. A. 87, 5061-5065; Chen, W. Y., White, M. E., Wagner, T.
E., and Kopchick, J. J.(1991) Endocrinology 129,
1402-1408; Chen, W. Y., Chen, N-Y., Yun, J., Wang, X. Z., Wagner,
T. E., and Kopchick, J. J.(1994) J. Biol. Chem. 269,
15892-15897). In this study, we report the ability of hGH and
hGH-G120R to be internalized by GH receptor expressing cells.
Additionally, results of chemical cross-linking experiments revealed
that both native hGH and hGH-G120R form complexes similar in size to
that expected for hGH when bound to recombinant hGH-binding protein
(bp). The molecular mass of the complex was determined to be
approximately 280 kDa which is consistent with multiple receptors
interacting with the ligand. The predominant radiolabeled band detected
was a complex of approximately 140 kDa which probably represents one GH
molecule bound to one GH receptor. The cross-linked complexes were not
detected in the presence of excess unlabeled hGH or hGH-G120R and were
not observed in cells which do not express detectable levels of GH
receptors. Also, GH induced tyrosine phosphorylation of a complex of
proteins of approximately 95 kDa in these cells whereas hGH-G120R did
not. Thus, we have separated the hGH or hGH-G120R/GHR binding and
internalization capabilities from the ability to stimulate tyrosine
phosphorylation of intracellular proteins.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
C. E. Higham and P. J. Trainer
Growth hormone excess and the development of growth hormone receptor antagonists
Exp Physiol,
November 1, 2008;
93(11):
1157 - 1169.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Swanson and J. J. Kopchick
Nuclear Localization of Growth Hormone Receptor: Another Age of Discovery for Cytokine Action?
Sci. Signal.,
December 4, 2007;
2007(415):
pe69 - pe69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Yang, X. Wang, J. Jiang, and S. J. Frank
Role of the Growth Hormone (GH) Receptor Transmembrane Domain in Receptor Predimerization and GH-Induced Activation
Mol. Endocrinol.,
July 1, 2007;
21(7):
1642 - 1655.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M J Waters, H N Hoang, D P Fairlie, R A Pelekanos, and R J Brown
New insights into growth hormone action
J. Mol. Endocrinol.,
February 1, 2006;
36(1):
1 - 7.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Q. Xu, B. S. Emerald, E. L. K. Goh, N. Kannan, L. D. Miller, P. D. Gluckman, E. T. Liu, and P. E. Lobie
Gene Expression Profiling to Identify Oncogenic Determinants of Autocrine Human Growth Hormone in Human Mammary Carcinoma
J. Biol. Chem.,
June 24, 2005;
280(25):
23987 - 24003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maamra, J. J. Kopchick, C. J. Strasburger, and R. J. M. Ross
Pegvisomant, a Growth Hormone-Specific Antagonist, Undergoes Cellular Internalization
J. Clin. Endocrinol. Metab.,
September 1, 2004;
89(9):
4532 - 4537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. F. Muller, J. J. Kopchick, A. Flyvbjerg, and A. J. van der Lely
Growth Hormone Receptor Antagonists
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1503 - 1511.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. D. Veldhuis, M. Bidlingmaier, S. M. Anderson, W. S. Evans, Z. Wu, and C. J. Strasburger
Impact of Experimental Blockade of Peripheral Growth Hormone (GH) Receptors on the Kinetics of Endogenous and Exogenous GH Removal in Healthy Women and Men
J. Clin. Endocrinol. Metab.,
December 1, 2002;
87(12):
5737 - 5745.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Lu, P. Scott, G. J. Strous, and L. A. Schuler
Multiple Internalization Motifs Differentially Used by Prolactin Receptor Isoforms Mediate Similar Endocytic Pathways
Mol. Endocrinol.,
November 1, 2002;
16(11):
2515 - 2527.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. Kopchick, C. Parkinson, E. C. Stevens, and P. J. Trainer
Growth Hormone Receptor Antagonists: Discovery, Development, and Use in Patients with Acromegaly
Endocr. Rev.,
October 1, 2002;
23(5):
623 - 646.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Gent, P. van Kerkhof, M. Roza, G. Bu, and G. J. Strous
Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis
PNAS,
July 23, 2002;
99(15):
9858 - 9863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Frank
Minireview: Receptor Dimerization in GH and Erythropoietin Action--It Takes Two to Tango, But How?
Endocrinology,
January 1, 2002;
143(1):
2 - 10.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, B. Kelder, and J. J. Kopchick
Identification, Isolation, and Cloning of Growth Hormone (GH)-Inducible Interscapular Brown Adipose Complementary Deoxyribonucleic Acid from GH Antagonist Mice
Endocrinology,
July 1, 2001;
142(7):
2937 - 2945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. M. Ross, K. C. Leung, M. Maamra, W. Bennett, N. Doyle, M. J. Waters, and K. K. Y. Ho
Binding and Functional Studies with the Growth Hormone Receptor Antagonist, B2036-PEG (Pegvisomant), Reveal Effects of Pegylation and Evidence That It Binds to a Receptor Dimer
J. Clin. Endocrinol. Metab.,
April 1, 2001;
86(4):
1716 - 1723.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
K. K. Kaulsay, T. Zhu, W. F. Bennett, K.-O. Lee, and P. E. Lobie
The Effects of Autocrine Human Growth Hormone (hGH) on Human Mammary Carcinoma Cell Behavior Are Mediated via the hGH Receptor
Endocrinology,
February 1, 2001;
142(2):
767 - 777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Bartke, V. Chandrashekar, D. Turyn, R. W. Steger, L. Debeljuk, T. A. Winters, J. A. Mattison, N. A. Danilovich, W. Croson, D. R. Wernsing, et al.
Effects of Growth Hormone Overexpression and Growth Hormone Resistance on Neuroendocrine and Reproductive Functions in Transgenic and Knock-Out Mice
Experimental Biology and Medicine,
November 1, 1999;
222(2):
113 - 123.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
V. A. Barr, K. Lane, and S. I. Taylor
Subcellular Localization and Internalization of the Four Human Leptin Receptor Isoforms
J. Biol. Chem.,
July 23, 1999;
274(30):
21416 - 21424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Maamra, J. Finidori, S. Von Laue, S. Simon, S. Justice, J. Webster, S. Dower, and R. Ross
Studies with a Growth Hormone Antagonist and Dual-fluorescent Confocal Microscopy Demonstrate that the Full-length Human Growth Hormone Receptor, but Not the Truncated Isoform, Is Very Rapidly Internalized Independent of Jak2-Stat5 Signaling
J. Biol. Chem.,
May 21, 1999;
274(21):
14791 - 14798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Ruan, L. Powell-Braxton, J. J. Kopchick, and D. L. Kleinberg
Evidence That Insulin-Like Growth Factor I and Growth Hormone Are Required for Prostate Gland Development
Endocrinology,
May 1, 1999;
140(5):
1984 - 1989.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
E Juarez-Aguilar, F Castro-Munozledo, N. Guerra-Rodriguez, D Resendez-Perez, H. Martinez-Rodriguez, H. Barrera-Saldana, and W Kuri-Harcuch
Functional domains of human growth hormone necessary for the adipogenic activity of hGH/hPL chimeric molecules
J. Cell Sci.,
January 9, 1999;
112(18):
3127 - 3135.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. J. E. Dore Jr., M. Edens, N. Garamszegi, and E. B. Leof
Heteromeric and Homomeric Transforming Growth Factor-beta Receptors Show Distinct Signaling and Endocytic Responses in Epithelial Cells
J. Biol. Chem.,
November 27, 1998;
273(48):
31770 - 31777.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Qiu, A. Belanger, H.-W. P. Yoon, and H. F. Bunn
Homodimerization Restores Biological Activity to an Inactive Erythropoietin Mutant
J. Biol. Chem.,
May 1, 1998;
273(18):
11173 - 11176.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. A. Anders, S. L. Arline, J. J.E. Doré, and E. B. Leof
Distinct Endocytic Responses of Heteromeric and Homomeric Transforming Growth Factor beta Receptors
Mol. Biol. Cell,
November 1, 1997;
8(11):
2133 - 2143.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Mellado, J. M. Rodriguez-Frade, L. Kremer, C. von Kobbe, A. M. de Ana, I. Merida, and C. Martinez-A
Conformational Changes Required in the Human Growth Hormone Receptor for Growth Hormone Signaling
J. Biol. Chem.,
April 4, 1997;
272(14):
9189 - 9196.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Sundstrom, T. Lundqvist, J. Rodin, LutzB. Giebel, D. Milligan, and G. Norstedt
Crystal Structure of an Antagonist Mutant of Human Growth Hormone, G120R, in Complex with Its Receptor at 2.9AResolution
J. Biol. Chem.,
December 13, 1996;
271(50):
32197 - 32203.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|